Our biochemical and biophysical studies coupled with in silico analysis led us to conclude that M3-α1AT cannot be considered as a normal variant of α1AT and could possibly play a key role in the pathogenesis of a host of diseases including COPD that warrants further insight. This evidence concerns the gene SERPINA1 and chronic obstructive pulmonary disease.